Valganciclovir Hydrochloride For Solution
Product Images NDC 72205-019

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Valganciclovir Hydrochloride (NDC 72205-019). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Valganciclovir-50mg-100ml-cntr-label (Valganciclovir 50mg 100ml Cntr Label)

Label for Valganciclovir for Oral Solution 50 mg/mL, an oral prescription drug formulation. The label indicates the solution contains 50 mg valganciclovir free base per mL after constitution to 100 mL. It includes storage instructions, manufacturer MSN Pharmaceuticals Inc., and distributor Novadoz Pharmaceuticals LLC contact details. The label also shows a 100 mL (3.4 fl oz) container icon and barcode.*

FDA Label Image

Valganciclovir-50mg-100ml-crtn-label (Valganciclovir 50mg 100ml Crtn Label)

Packaging label for Valganciclovir Oral Solution 50 mg/mL by Novadoz Pharmaceuticals LLC. The label indicates a 100 mL (3.4 fl oz) oral solution containing 50 mg valganciclovir free base per mL. It includes NDC 72205-019-01 and instructions about storage and preparation of the constituted solution. The label also notes the prescription status (Rx Only) and provides distributor contact information.*

FDA Label Image

Valganciclovir-dose-calculation-formula (Valganciclovir Dose Calculation Formula)

An illustration showing two medical formulas: one for calculating body surface area (Mosteller BSA) and another for estimating creatinine clearance (Schwartz formula). The formulas involve variables such as height, weight, and serum creatinine, typically used in clinical dosing calculations.*

FDA Label Image

Valganciclovir-fig-1 (Valganciclovir Fig 1)

An instructional diagram showing components of an oral liquid medication: a bottle with a child resistant cap and bottle adapter, and a separate oral dispenser consisting of a plunger, barrel with volume markings up to 10 mL, and tip for administration.*

FDA Label Image

Valganciclovir-fig-10 (Valganciclovir Fig 10)

An instructional diagram showing the proper method to open a child-resistant safety cap on a bottle, illustrating pressing down and turning the cap.*

FDA Label Image

Valganciclovir-fig-11 (Valganciclovir Fig 11)

An instructional illustration showing liquid drops falling from a faucet into an oral syringe. An oral syringe is depicted at an angle to catch the liquid drops, indicating a method of measuring or administering liquid medication.*

FDA Label Image

Valganciclovir-fig-12 (Valganciclovir Fig 12)

A black and white illustration of an oral dosing syringe graduated in milliliters from 0 to 10, used for measuring and administering liquid medication doses.*

FDA Label Image

Valganciclovir-fig-2 (Valganciclovir Fig 2)

An instructional illustration showing a hand holding an oral solution bottle with an arrow and text indicating to 'Shake well.' This suggests proper preparation before use of the liquid medication.*

FDA Label Image

Valganciclovir-fig-3 (Valganciclovir Fig 3)

An instructional diagram showing a bottle with a child-resistant cap. The illustration depicts an arrow pointing down onto the cap and a circular arrow indicating to press down and turn to open the bottle.*

FDA Label Image

Valganciclovir-fig-4 (Valganciclovir Fig 4)

An illustration showing an oral syringe with a labeled dosage indicator in milliliters (mL), used to measure liquid medication doses accurately.*

FDA Label Image

Valganciclovir-fig-5 (Valganciclovir Fig 5)

An instructional line drawing showing a hand holding a syringe for oral solution administration, demonstrating the pressing down of the plunger.*

FDA Label Image

Valganciclovir-fig-6 (Valganciclovir Fig 6)

An instructional illustration depicting the process of inserting a bottle adapter into a bottle opening. A hand is shown holding a syringe or measuring device aligned above the bottle, with an arrow indicating downward motion towards the bottle adapter opening. This image is likely part of a medication administration guide for an oral solution.*

FDA Label Image

Valganciclovir-fig-7 (Valganciclovir Fig 7)

An instructional diagram showing how to draw oral valganciclovir hydrochloride solution from a bottle using an oral syringe. The image depicts a hand holding the bottle upside down, connected to the syringe, illustrating the extraction of the liquid medication into the syringe.*

FDA Label Image

Valganciclovir-fig-8 (Valganciclovir Fig 8)

An instructional illustration showing a hand using a syringe to withdraw liquid medication from a bottle. The syringe is inserted into the bottle's opening with an arrow indicating upward movement to draw the solution into the syringe.*

FDA Label Image

Valganciclovir-formula (Valganciclovir Formula)

A text panel showing a pharmacokinetic formula for males calculating a value based on age in years, body weight in kilograms, and serum creatinine in mg/dL. The formula is represented as (140 minus age) times body weight, divided by 72 times serum creatinine.*

FDA Label Image

Valganciclovir-structural-formula (Valganciclovir Structural Formula)

Chemical structure of valganciclovir hydrochloride, an antiviral drug. The structure includes a guanine base linked to a sugar moiety and an ester group, with the molecule shown in its hydrochloride salt form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.